Literature DB >> 16364512

A mutation inactivating the methyltransferase gene in avirulent Madrid E strain of Rickettsia prowazekii reverted to wild type in the virulent revertant strain Evir.

Jian-Zhi Zhang1, Jun-Fang Hao, David H Walker, Xue-Jie Yu.   

Abstract

Rickettsia prowazekii Madrid E (E) strain is an effective vaccine, but can revert to virulent status when passaged in animals. The aim of this study is to identify the reverse mutation that may determine the virulence of R. prowazekii by comparing the genetic structures of E strain and its virulent revertant Evir strain. We determined that the gene (Rp028/Rp027) encoding the methyltransferase was mutated by frameshift in avirulent E strain but not in virulent revertant Evir strain and wild type virulent Breinl strain. We conclude that the mutation in the E strain gene reverts to wild type in the virulent revertant Evir strain. Whether the mutation plays an essential role in the attenuation of E strain needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364512     DOI: 10.1016/j.vaccine.2005.11.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Rickettsia buchneri sp. nov., a rickettsial endosymbiont of the blacklegged tick Ixodes scapularis.

Authors:  Timothy J Kurtti; Roderick F Felsheim; Nicole Y Burkhardt; Jonathan D Oliver; Chan C Heu; Ulrike G Munderloh
Journal:  Int J Syst Evol Microbiol       Date:  2015-01-06       Impact factor: 2.747

2.  Structural Insights into Substrate Recognition and Catalysis in Outer Membrane Protein B (OmpB) by Protein-lysine Methyltransferases from Rickettsia.

Authors:  Amila H Abeykoon; Nicholas Noinaj; Bok-Eum Choi; Lindsay Wise; Yi He; Chien-Chung Chao; Guanghui Wang; Marjan Gucek; Wei-Mei Ching; P Boon Chock; Susan K Buchanan; David C H Yang
Journal:  J Biol Chem       Date:  2016-07-29       Impact factor: 5.157

Review 3.  Engineering of obligate intracellular bacteria: progress, challenges and paradigms.

Authors:  Erin E McClure; Adela S Oliva Chávez; Dana K Shaw; Jason A Carlyon; Roman R Ganta; Susan M Noh; David O Wood; Patrik M Bavoil; Kelly A Brayton; Juan J Martinez; Jere W McBride; Raphael H Valdivia; Ulrike G Munderloh; Joao H F Pedra
Journal:  Nat Rev Microbiol       Date:  2017-06-19       Impact factor: 60.633

4.  Genomic, proteomic, and transcriptomic analysis of virulent and avirulent Rickettsia prowazekii reveals its adaptive mutation capabilities.

Authors:  Yassina Bechah; Khalid El Karkouri; Oleg Mediannikov; Quentin Leroy; Nicolas Pelletier; Catherine Robert; Claudine Médigue; Jean-Louis Mege; Didier Raoult
Journal:  Genome Res       Date:  2010-04-05       Impact factor: 9.043

Review 5.  The realities of biodefense vaccines against Rickettsia.

Authors:  David H Walker
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

6.  Two protein lysine methyltransferases methylate outer membrane protein B from Rickettsia.

Authors:  Amila H Abeykoon; Chien-Chung Chao; Guanghui Wang; Marjan Gucek; David C H Yang; Wei-Mei Ching
Journal:  J Bacteriol       Date:  2012-09-21       Impact factor: 3.490

7.  Multimethylation of Rickettsia OmpB catalyzed by lysine methyltransferases.

Authors:  Amila Abeykoon; Guanghui Wang; Chien-Chung Chao; P Boon Chock; Marjan Gucek; Wei-Mei Ching; David C H Yang
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

8.  Directed mutagenesis of the Rickettsia prowazekii pld gene encoding phospholipase D.

Authors:  Lonnie O Driskell; Xue-jie Yu; Lihong Zhang; Yan Liu; Vsevolod L Popov; David H Walker; Aimee M Tucker; David O Wood
Journal:  Infect Immun       Date:  2009-06-08       Impact factor: 3.441

9.  Proteomic analysis of Rickettsia parkeri strain portsmouth.

Authors:  Walairat Pornwiroon; Apichai Bourchookarn; Christopher D Paddock; Kevin R Macaluso
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

10.  Genotyping Rickettsia prowazekii isolates.

Authors:  Yong Zhu; Aaron Medina-Sanchez; Donald Bouyer; David H Walker; Xue-Jie Yu
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.